CHESHIRE, UK--(Marketwire - August 06, 2008) - London, UK; Brentwood, TN, US; 6 August 2008 - Protherics PLC (“Protherics” or the “Company”), the international biopharmaceutical company focused on critical care and cancer, today announces that data from the “DEEP” study has been selected as one of the key presentations at the 16th World Congress of The International Society for the Study of Hypertension in Pregnancy (ISSHP) in Washington DC, US 21-25 September 2008.
